https://www.openbell.ai/ 2026-10-20T12:35:49.611Z hourly 1.0 https://www.openbell.ai/support 2026-10-20T12:35:49.611Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-20T12:35:49.611Z monthly 0.5 https://www.openbell.ai/terms 2026-10-20T12:35:49.611Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-20T12:35:49.611Z hourly 0.8 https://www.openbell.ai/news/KMTS:1792499738409 2026-10-20T12:35:38.409Z daily 0.9 https://cdn.brandfetch.io/KMTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evercore ISI Group Initiates Coverage On Kestra Medical Techs with Outperform Rating, Announces Price Target of $34 Evercore ISI Group has initiated coverage on Kestra Medical Techs (NASDAQ: KMTS) with an Outperform rating. The firm has set a price target of $34 for the company's stock. https://www.openbell.ai/news/IRON:1792499727565 2026-10-20T12:35:27.565Z daily 0.9 https://cdn.brandfetch.io/IRON/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Maintains Outperform on Disc Medicine, Raises Price Target to $110 Wedbush analyst David Nierengarten has maintained an 'Outperform' rating on Disc Medicine (NASDAQ: IRON) and increased the price target from $100 to $110. This adjustment reflects positive expectations for the company's performance in the market. https://www.openbell.ai/news/GMEX:1792499724388 2026-10-20T12:35:24.388Z daily 0.9 https://cdn.brandfetch.io/GMEX/w/400/h/400?c=1idopYfmtR7ZKg8QMud GMEX Robotics' Alpha Meta AI Starts Co-Development Project With U.S.-Based Customers To Product AI-Powered Autonomous Adaptive Canine Washing, Grooming Station GMEX Robotics Corporation (NASDAQ: GMEX) announced that its strategic investee, Alpha Meta AI Pte. Ltd., has begun a co-development project with U.S.-based clients to create an AI-powered autonomous adaptive canine washing and grooming station. This initiative highlights GMEX's focus on integrating AI technology into robotics and intelligent automation. https://www.openbell.ai/news/FRNM:1792499676549 2026-10-20T12:34:36.549Z daily 0.9 https://cdn.brandfetch.io/FRNM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Freenome Unveils SimpleScreen Lung Enabling Patients To Be Screened For Lung And Colorectal Cancer Through Single Blood Draw, Using Two Independently Validated, Indication-Specific Tests Freenome, Inc. (NASDAQ: FRNM) has launched SimpleScreen Lung, a novel offering that allows patients to be screened for both lung and colorectal cancer through a single blood draw using two validated tests. The SimpleScreen Lung test demonstrated 85% sensitivity at 50% specificity and a 99.8% negative predictive value for lung cancer in its intended use population. This initiative aims to enhance screening participation, particularly among the over 10 million eligible individuals for lung cancer and 60 million for colorectal cancer who are not currently up to date with standard screening methods. https://www.openbell.ai/news/JCSE:1792499656591 2026-10-20T12:34:16.591Z daily 0.9 https://cdn.brandfetch.io/JCSE/w/400/h/400?c=1idopYfmtR7ZKg8QMud JE Cleantech Hldgs H1 EPS $0.25 Up From $(0.12) YoY, Sales $16.084M Up From $5.106M YoY JE Cleantech Holdings (NASDAQ: JCSE) reported a first-half earnings per share (EPS) of $0.25, a significant increase from a loss of $(0.12) per share year-over-year, representing a 308.33% improvement. The company's sales reached $16.084 million, marking a 215.00% increase from $5.106 million in the same period last year. https://www.openbell.ai/news/GPC:1792499594306 2026-10-20T12:33:14.306Z daily 0.9 https://cdn.brandfetch.io/GPC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Genuine Parts Slashes 2026 Profit Outlook, Stock Falls Genuine Parts Co. (NYSE: GPC) reported mixed third-quarter results, with adjusted earnings of $2.07 per share surpassing analyst estimates of $2.05, while revenue of $6.521 billion fell short of expectations of $6.523 billion. The company lowered its 2026 GAAP earnings forecast to $5.60 to $5.85 per share, down from $5.90 to $6.40, and also narrowed its adjusted earnings forecast to $7.50 to $7.75 per share. Following the announcement, GPC shares fell 6.28% to $122.00 in premarket trading. https://www.openbell.ai/news/MBOT:1792499569625 2026-10-20T12:32:49.625Z daily 0.9 https://cdn.brandfetch.io/MBOT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Microbot Medical Receives Several New Patent Approvals Across US, Japan, China And Canada, Further Strengthening Its Global IP Portfolio Microbot Medical Inc. has received multiple patent approvals in the U.S., Japan, China, and Canada, enhancing its global intellectual property portfolio to 44 issued patents and 49 pending applications. The company is focused on advancing the commercialization of its LIBERTY® Endovascular Robotic System in both domestic and international markets while pursuing a CE Mark. These developments are part of Microbot's strategy to protect its innovations and support future market expansion. https://www.openbell.ai/news/NBIX:1792499498552 2026-10-20T12:31:38.552Z daily 0.9 https://cdn.brandfetch.io/NBIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Neurocrine Biosciences Starts Phase 2 Clinical Trial Of NBI-1117567 To Treat Adults With Mild To Moderate Alzheimer's Disease Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has commenced a Phase 2 clinical trial for its investigational compound NBI-1117567, aimed at treating adults with mild to moderate Alzheimer's disease. NBI-1117567 is an orally administered selective muscarinic agonist, specifically targeting M1/M4 receptors, and is being evaluated as an adjunctive treatment for cognitive impairment associated with the disease. https://www.openbell.ai/news/QSR:1792499473695 2026-10-20T12:31:13.695Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Konskie--Poland---November-24--2024-Rest.jpg?width=250&height=187 This Restaurant Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Mizuho analyst Nick Setyan initiated coverage on Restaurant Brands International Inc (NYSE: QSR) with an Outperform rating and set a price target of $85, while the stock closed at $74.34 on Monday. This marks a positive outlook for the company as it joins other firms receiving new analyst ratings. The article also highlights similar coverage initiations for other companies, including Adarx Pharmaceuticals and Modine Manufacturing Co. https://www.openbell.ai/news/OESX:1792499461724 2026-10-20T12:31:01.724Z daily 0.9 https://cdn.brandfetch.io/OESX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Orion Energy Systems Secures LED Lighting, Electrical Infrastructure And EV Charging Station Engagements From A Global Automobile Manufacturer Orion Energy Systems has secured contracts with a global automobile manufacturer to provide LED lighting, electrical infrastructure, and EV charging stations. These engagements are part of an ongoing partnership and will generate up to $1.4 million in revenue for Orion in FY 2027. The projects include upgrades at U.S. manufacturing and distribution facilities and mark Orion's first EV deployment with this customer. https://www.openbell.ai/news/SYNA:1792499433583 2026-10-20T12:30:33.583Z daily 0.9 https://cdn.brandfetch.io/SYNA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Synaptics Announces Availability Of Its Synaptics Coralboard For Purchase Through DigiKey Synaptics Incorporated (NASDAQ: SYNA) has announced that its latest version of the Synaptics Coralboard is now available for purchase through DigiKey. Developed in collaboration with Google Research, the Coralboard SL is powered by the Synaptics Astra SL2619 and features the Synaptics Torq NPU. This product is designed for ultra-low power applications and aims to provide efficient on-device inference for resource-constrained devices. https://www.openbell.ai/news/BAC:1792499416585 2026-10-20T12:30:16.585Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/2024-11-15-Los-Angeles-Usa-Bank-Of-Ameri.jpg?width=250&height=187 Bank Stocks Are On Their Longest Losing Streak Since 2008: Rates Aren't The Only Problem The KBW Nasdaq Bank Index, tracking 24 major U.S. banks, has fallen for six consecutive weeks, marking its longest losing streak since July 2008, with a decline of 1.1% on Monday. The index closed at 167.15 points, down 11.8% since early September and 13.8% from its record close of 193.91 on August 14. Bank of America reported a third-quarter net income of $6.9 billion, down from $8.3 billion a year earlier, and is currently trading about 23% below its 2026 high. None of the banks in the index are above their 50-day moving average, indicating widespread weakness in the sector. https://www.openbell.ai/news/ASTC:1792499329903 2026-10-20T12:28:49.903Z daily 0.9 https://cdn.brandfetch.io/ASTC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Astrotech Submits Proposal For The NASA Next Space Technologies For Exploration Partnerships-3 Lunar Enabling Infrastructure Accelerator Regarding Its Vertical Solar Array Astrotech has submitted a proposal for the NASA Next Space Technologies for Exploration Partnerships-3, focusing on the Astrotech Vertical Solar Array Maturation (AVSAM) project. The initiative aims to advance the Astrotech Mobile Power System (AMPS) from Technology Readiness Level 4 to 6, featuring a 120-volt direct-current interface capable of 6 kilowatts of continuous power. If selected, Astrotech will collaborate with Skycorp for development and testing, while also exploring the establishment of Lunar Utilities Corporation to provide power services on the lunar surface. https://www.openbell.ai/news/ADRX:1792499221314 2026-10-20T12:27:01.314Z daily 0.9 https://cdn.brandfetch.io/ADRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Initiates Coverage On Adarx Pharmaceuticals with Buy Rating, Announces Price Target of $35 UBS analyst Michael Yee has initiated coverage on Adarx Pharmaceuticals (NASDAQ: ADRX) with a Buy rating. The firm has set a price target of $35 for the company's stock. https://www.openbell.ai/news/GNS:1792499202233 2026-10-20T12:26:42.233Z daily 0.9 https://cdn.brandfetch.io/GNS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Genius Group Says Financial Wins In Last Quarter Are Underpinned By Our Legal Wins; Now Free To Pursue $1.2B Capital Plan We Announced In August To Fund Our Dual AI And Bitcoin Treasury Strategy, Relaunched Bitcoin Treasury In Early October; On September 27, Federal Court Denied All Motions To Dismiss Our RICO Lawsuit Genius Group reported significant progress in Q3, achieving a profitable $10 million model through its Genius City initiative, which integrates AI-powered education and reskilling. The company is now positioned to pursue a $1.2 billion capital plan announced in August, following legal victories including the vacating of an injunction that restricted share issuance and the denial of motions to dismiss a RICO lawsuit. The relaunch of their Bitcoin treasury in early October aligns with their dual strategy focusing on AI and Bitcoin. https://www.openbell.ai/news/BRZE:1792499100838 2026-10-20T12:25:00.838Z daily 0.9 https://cdn.brandfetch.io/BRZE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times openbell Financial News https://www.openbell.ai/news/ACLS:1792499066455 2026-10-20T12:24:26.455Z daily 0.9 https://cdn.brandfetch.io/ACLS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Axcelis Technologies To Start Construction On Its Implantation Equipment Production site In South Korea Under Its $35M Investment Plan Axcelis Technologies, Inc. (Nasdaq: ACLS) has announced plans to begin construction on a new ion implantation equipment manufacturing facility in Pyeongtaek, South Korea, as part of a $35 million investment. This initiative aims to enhance the company's high-volume manufacturing capabilities and expand its global service capacity in the semiconductor industry. https://www.openbell.ai/news/KZIA:1792499057643 2026-10-20T12:24:17.643Z daily 0.9 https://cdn.brandfetch.io/KZIA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Leerink Partners Initiates Coverage On Kazia Therapeutics with Outperform Rating, Announces Price Target of $30 Leerink Partners has initiated coverage on Kazia Therapeutics (NASDAQ: KZIA) with an Outperform rating. The firm has set a price target of $30 for the company's stock. https://www.openbell.ai/news/GNS:1792498980408 2026-10-20T12:23:00.408Z daily 0.9 https://cdn.brandfetch.io/GNS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Genius Group Says Financial Wins In Last Quarter Are Underpinned By Our Legal Wins; Now Free To Pursue $1.2B Capital Plan We Announced In August To Fund Our Dual AI And Bitcoin Treasury Strategy, Relaunched Bitcoin Treasury In Early October; On September 27, Federal Court Denied All Motions To Dismiss Our Rico Lawsuit openbell Financial News https://www.openbell.ai/news/AAPL:1792498925020 2026-10-20T12:22:05.020Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Ljubljana--Slovenia---2022-September-18-.jpg?width=250&height=187 This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday Analysts have downgraded several companies, including Apple Inc., which was downgraded from Buy to Hold by Loop Capital, with a reduced price target from $370 to $330. Apple shares closed at $342.94 on Monday. Other notable downgrades include Werner Enterprises, Zoetis, Heartland Express, and Elanco Animal Health, with respective price target reductions and current share prices reflecting their new ratings. https://www.openbell.ai/news/AAPL:1792498899314 2026-10-20T12:21:39.314Z daily 0.9 https://cdn.brandfetch.io/AAPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Apple Commits Up To $100M Over Three Years With American Manufacturing Program Partner Perryman For iPhone Duo Titanium; Expands Qnity Electronics Partnership For iPhone 18 Pro Camera openbell Financial News https://www.openbell.ai/news/USO:1792498823775 2026-10-20T12:20:23.775Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Russia Ships the Least Oil in a Month as Major Baltic Port Halts' - Bloomberg In October 2026, Russia experienced its lowest oil shipments in a month due to a significant halt at a major Baltic port. This disruption has raised concerns about supply levels and potential impacts on global oil markets. The situation may affect oil prices and the operations of related companies, including those represented by the USO stock ticker. https://www.openbell.ai/news/AGCO:1792498613390 2026-10-20T12:16:53.390Z daily 0.9 https://cdn.brandfetch.io/AGCO/w/400/h/400?c=1idopYfmtR7ZKg8QMud AGCO Inks Commercial Deal With Agility Robotics Over Future Production Through AI-Powered Humanoid Automation AGCO has entered into a commercial agreement with Agility Robotics to enhance manufacturing through AI-powered humanoid automation. A pilot program is set to commence in 2027 at AGCO's production facility in Hesston, Kansas, aimed at developing more flexible and intelligent factories. https://www.openbell.ai/news/UNH:1792498610692 2026-10-20T12:16:50.692Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Experts-Warn-Of-Steep-Reductions.jpg?width=250&height=187 Twilio, Transocean and a Health Care Stock on CNBC’s ‘Final Trades’ On CNBC's 'Final Trades', Stephen Weiss recommended UnitedHealth Group (NYSE: UNH) after it reported third-quarter earnings of $4.69 per share, surpassing the consensus estimate of $4.15, and quarterly sales of $112.694 billion, exceeding expectations of $111.403 billion. Joseph M. Terranova endorsed Twilio Inc. (NYSE: TWLO), supported by BTIG's analyst Nick Altmann who raised its price target from $285 to $315. Jim Lebenthal suggested Transocean Ltd. (NYSE: RIG), which secured two contracts worth approximately $550 million for ultra-deepwater drillships. Following these recommendations, UnitedHealth shares rose 1.4% to $406.88, Twilio shares increased 5.3% to $257.29, and Transocean shares climbed 4.8% to $5.89. https://www.openbell.ai/news/META:1792498597246 2026-10-20T12:16:37.246Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/20/Mark-Zuckerberg-Image-On-Mobile-Screen-A.jpg?width=250&height=187 Meta Q3 Earnings Preview: Wall Street Eyes Muse AI Monetization As Mark Zuckerberg's AI Bet Faces Its Next Test Meta Platforms Inc. is set to report its Q3 earnings on October 21, with analysts expecting $63.36 billion in revenue and $5.89 in earnings per share. The company is focusing on monetizing its Muse AI models, with projections estimating Muse revenue could reach $29 billion by 2030. Additionally, Morgan Stanley raised its price target for Meta to $820, citing strong advertising trends and anticipated revenue growth from high-margin AI subscriptions. META stock was down 1.05% in premarket trading, but is up 6.87% year-to-date. https://www.openbell.ai/news/HOST:1792498555767 2026-10-20T12:15:55.767Z daily 0.9 https://cdn.brandfetch.io/HOST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Host Digital Announces Buyback Program Of Up To $15M openbell Financial News https://www.openbell.ai/news/ELAN:1792498415995 2026-10-20T12:13:35.995Z daily 0.9 https://cdn.brandfetch.io/ELAN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jefferies Downgrades Elanco Animal Health to Hold, Lowers Price Target to $24 Jefferies analyst Keith Devas has downgraded Elanco Animal Health (NYSE: ELAN) from a 'Buy' to 'Hold' rating. The price target for the company's stock has been reduced from $31 to $24. https://www.openbell.ai/news/RNA:1792498379913 2026-10-20T12:12:59.913Z daily 0.9 https://cdn.brandfetch.io/RNA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shareholder Yakira Capital Urges Atrium Therapeutics To Explore Strategic Sale Or Partnerships, Citing 44% Stock Decline, $50M Dilutive Financing Yakira Capital Management has urged Atrium Therapeutics' Board to explore strategic alternatives, citing a 44% decline in stock price and a recent $50 million dilutive financing. The financing involved approximately 5.17 million common shares at an effective price of $7.93 per share, raising concerns about shareholder value given the stock's valuation near 50% of net cash. Yakira highlights Atrium's estimated net cash of $254 million and potential value from collaborations and internal development, questioning the Board's decision-making and urging for a strategic review to protect shareholder interests. https://www.openbell.ai/news/MCK:1792498326984 2026-10-20T12:12:06.984Z daily 0.9 https://cdn.brandfetch.io/MCK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Mizuho Maintains Neutral on McKesson, Raises Price Target to $1020 Mizuho analyst Steven Valiquette has maintained a Neutral rating on McKesson (NYSE: MCK) while raising the price target from $905 to $1020. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/GNS:1792498292625 2026-10-20T12:11:32.625Z daily 0.9 https://cdn.brandfetch.io/GNS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Genius Group Q3 Revenue $4.1M, Gross Profit Rises 108% To $2.7M, And Operating Profit Reaches $235K; 9-Month Revenue Climbs 112% To $10.3M openbell Financial News https://www.openbell.ai/news/CAH:1792498251967 2026-10-20T12:10:51.967Z daily 0.9 https://cdn.brandfetch.io/CAH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280 Mizuho analyst Steven Valiquette has maintained an 'Outperform' rating on Cardinal Health (NYSE: CAH) and raised the price target from $250 to $280. https://www.openbell.ai/news/QSR:1792498202745 2026-10-20T12:10:02.745Z daily 0.9 https://cdn.brandfetch.io/QSR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Mizuho Initiates Coverage On Restaurant Brands Intl with Outperform Rating, Announces Price Target of $85 Mizuho analyst Nick Setyan has initiated coverage on Restaurant Brands International (NYSE: QSR) with an Outperform rating. The firm has set a price target of $85 for the company's stock. https://www.openbell.ai/news/PALI:1792498192267 2026-10-20T12:09:52.267Z daily 0.9 https://cdn.brandfetch.io/PALI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Palisade Bio Announces Findings Presented At United European Gastroenterology Week; Five-Patient Phase 1B Crohn’s Disease Cohort Showed 47.5% Reduction In Mean Endoscopic Disease Activity And 58.8% Reduction In Mean Fecal Calprotectin After 14 Days; Phase 2b ASCENTRA-UC Study Is Enrolling; Phase 2a Crohn’s Disease Study Being Initiated Palisade Bio presented findings at the United European Gastroenterology Week 2026, showing a 47.5% reduction in mean endoscopic disease activity and a 58.8% reduction in mean fecal calprotectin in a five-patient Phase 1b study for Crohn's disease after 14 days. The company is currently enrolling patients for the Phase 2b ASCENTRA-UC study and initiating a Phase 2a study for Crohn's disease. The findings support the development of PALI-2108 as a once-daily oral treatment targeting intestinal inflammation, with favorable short-term tolerability reported in the study cohort. https://www.openbell.ai/news/SOAR:1792498127737 2026-10-20T12:08:47.737Z daily 0.9 https://cdn.brandfetch.io/SOAR/w/400/h/400?c=1idopYfmtR7ZKg8QMud SOAR AI Says Ohio Compute Campus Remains On Track For First 4,096 AMD MI355X GPUs By Dec. 31; Expects Orders To Generate Revenue Of ~$175M-$200M In 2027 SOAR AI, Inc. (NYSE: SOAR) announced that its AI compute campus in Chillicothe, Ohio, is on track to deploy its first 4,096 AMD MI355X GPUs by December 31, 2026, with customer revenue expected to commence in January 2027. The company has approximately $1.2 billion in contracted capacity, which is projected to generate revenue of $175 million to $200 million in 2027. The deployment is supported by a master services agreement and two four-year, take-or-pay orders, providing long-term revenue visibility. https://www.openbell.ai/news/OBAI:1792498105049 2026-10-20T12:08:25.049Z daily 0.9 https://cdn.brandfetch.io/OBAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Our Bond Selected By Unnamed S&P 500 Financial Technology Company To Provide Personal Security For Executives, At-Risk Employees openbell Financial News https://www.openbell.ai/news/HLSQ:1792498090221 2026-10-20T12:08:10.221Z daily 0.9 https://cdn.brandfetch.io/HLSQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tessera Defense Subsidiary Zorronet Receives Initial Defense AI Order For 2 Units, With Potential Follow-On Order Of Up To 1,000 Units Subject To Successful Testing Zorronet Ltd., a subsidiary of Tessera Defense and Homeland Security Inc. (NYSE: HLSQ), has received an initial order for two units of its new Edge AI system from a leading global defense company. The system, which integrates thermal sensing and AI for real-time event detection and response, may lead to a follow-on order of up to 1,000 units pending successful field testing. This marks a significant advancement in Zorronet's defense business, transitioning from prototype development to operational system orders. https://www.openbell.ai/news/AORT:1792498030541 2026-10-20T12:07:10.541Z daily 0.9 https://cdn.brandfetch.io/AORT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jefferies Initiates Coverage On Artivion with Buy Rating, Announces Price Target of $31 Jefferies analyst Michael Sarcone has initiated coverage on Artivion (NYSE: AORT) with a Buy rating. The firm has set a price target of $31 for the company's stock. https://www.openbell.ai/news/ABBV:1792498017970 2026-10-20T12:06:57.970Z daily 0.9 https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud AbbVie Says Health Canada Approves Skyrizi For Moderate To Severe Plaque Psoriasis In Patients Aged 6 To Under 18 openbell Financial News https://www.openbell.ai/news/FRTT:1792497940359 2026-10-20T12:05:40.359Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session In Tuesday's pre-market session, Fort Technology (NASDAQ:FRTT) saw a significant increase of 18.3%, reaching $0.64, with a market cap of $8.0 million. Other notable gainers included Epsium Enterprise (NASDAQ:EPSM), which rose by 11.34% to $1.08, and Hesai Gr (NASDAQ:HSAI), up 9.21% to $14.11, with a market cap of $2.0 billion. Conversely, Xcel Brands (NASDAQ:XELB) experienced the largest decline, dropping 8.2% to $0.39, while General Motors (NYSE:GM) fell 7.38% to $76.65 following the release of its Q3 earnings. https://www.openbell.ai/news/WORX:1792497940135 2026-10-20T12:05:40.135Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Health Care Stocks Moving In Tuesday's Pre-Market Session In Tuesday's pre-market session, SCWorx (NASDAQ: WORX) saw a significant increase of 47.8%, reaching $3.96. Integra Lifesciences (NASDAQ: IART) shares rose by 31.97% to $17.75, with a market value of $1.0 billion, while Rapport Therapeutics (NASDAQ: RAPP) increased by 23.25% to $35.25, valuing its outstanding shares at $1.3 billion. Conversely, China SXT Pharmaceuticals (NASDAQ: SXTC) experienced a sharp decline of 41.5%, dropping to $0.07. https://www.openbell.ai/news/CSTE:1792497939859 2026-10-20T12:05:39.859Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Industrials Stocks Moving In Tuesday's Pre-Market Session In Tuesday's pre-market session, Caesarstone (NASDAQ:CSTE) shares rose by 15.34% to $2.48, with a market value of $74.3 million. Other notable gainers included WF Holding (WFF), which increased by 28.6% to $0.12, and CBAK Energy Technology (CBAT), up 11.95% to $1.03. Conversely, Stardust Power (SDST) saw the largest decline, dropping 30.9% to $0.02. https://www.openbell.ai/news/AAPL:1792497939788 2026-10-20T12:05:39.788Z daily 0.9 https://cdn.brandfetch.io/AAPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Apple Commits Up To $100M Over Three Years With American Manufacturing Program Partner Perryman For iPhone Duo Titanium; Expands Qnity Electronics Partnership For iPhone 18 Pro Camera openbell Financial News https://www.openbell.ai/news/AIXI:1792497939649 2026-10-20T12:05:39.649Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Information Technology Stocks Moving In Tuesday's Pre-Market Session In Tuesday's pre-market session, XIAO-I (NASDAQ:AIXI) shares surged 26.2% to $2.78, with a market cap of $29.0 million. Other notable gainers included ARB IOT Group (NASDAQ:ARBB), which rose 15.08% to $4.5, and Klaviyo (NYSE:KVYO), which increased by 10.78% to $19.41, reaching a market value of $4.9 billion. Conversely, Exascale Labs Holdings (NASDAQ:XLAB) saw a decline of 14.1% to $2.63, with a market value of $196.8 million. https://www.openbell.ai/news/V:1792497904101 2026-10-20T12:05:04.101Z daily 0.9 https://cdn.brandfetch.io/V/w/400/h/400?c=1idopYfmtR7ZKg8QMud Visa Partners With Bill.com And Billtrust To Launch First Live Pilot For Trusted AI Agents To Initiate And Complete Approved Buyer Invoice Payments Visa has partnered with BILL and Billtrust to launch the first live pilot for trusted AI agents that can initiate and complete approved buyer invoice payments, enhancing payment automation. This initiative utilizes Visa's Trusted Agent Protocol to securely authenticate AI agents, allowing them to automate payments while maintaining supplier control. The pilot aims to streamline B2B payments by providing tokenized payment credentials and ensuring compliance with customer payment instructions, ultimately accelerating cash flow for Billtrust customers. https://www.openbell.ai/news/RZLV:1792497877283 2026-10-20T12:04:37.283Z daily 0.9 https://cdn.brandfetch.io/RZLV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rezolve AI Signs Commercial Agreement With Revolut To Deliver Transaction-Linked Rewards To Eligible Customers Rezolve Ai (NASDAQ: RZLV) has signed a commercial agreement with Revolut to provide transaction-linked rewards to eligible customers, enhancing its ability to connect merchants with consumers. This partnership aims to expand merchant participation and drive organic growth through broader distribution in agreed markets. The agreement is part of Rezolve Ai's strategy to integrate customer engagement and loyalty into everyday financial platforms. https://www.openbell.ai/news/RVMD:1792497812509 2026-10-20T12:03:32.509Z daily 0.9 https://cdn.brandfetch.io/RVMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Revolution Medicines Begins Treating Patients In Phase 3 RASolve 308 Trial openbell Financial News https://www.openbell.ai/news/LAES:1792497797744 2026-10-20T12:03:17.744Z daily 0.9 https://cdn.brandfetch.io/LAES/w/400/h/400?c=1idopYfmtR7ZKg8QMud WISeSat.Space Announces Successful Launch And Deployment Of FOSSASAT-2E27, Its 6U Satellite Aboard SpaceX's Falcon 9 Bandwagon-5 Mission WISeSat.Space successfully launched its 6U satellite, FOSSASAT-2E27, aboard SpaceX's Falcon 9 Bandwagon-5 mission. The satellite incorporates VaultIC secure-element technology from SEALSQ Corp., enhancing WISeSat's technology-validation roadmap. This mission is part of an extended collaboration with FOSSA, which includes up to six satellite missions aimed at advancing in-orbit testing of cybersecurity technologies. The partnership is strategically positioned to meet growing post-quantum security requirements as outlined in U.S. Executive Order 14412, with implementation expected by 2030. https://www.openbell.ai/news/SNY:1792497762337 2026-10-20T12:02:42.337Z daily 0.9 https://cdn.brandfetch.io/SNY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Teva Pharma And Sanofi Report Duvakitug Maintained Efficacy Through 44 Weeks In Ulcerative Colitis And Crohn's Disease Teva Pharmaceuticals and Sanofi reported positive results from the RELIEVE UCCD phase 2b long-term extension study, showing that the investigational drug duvakitug maintained high rates of clinical remission and response in patients with ulcerative colitis (UC) and Crohn's disease (CD) over 44 weeks. The study involved 130 patients and demonstrated that duvakitug was well tolerated, with safety consistent with previous findings. The data, which also included biomarker insights on inflammation and tissue remodeling, were presented at the United European Gastroenterology Week 2026. https://www.openbell.ai/news/CIRC:1792497738377 2026-10-20T12:02:18.377Z daily 0.9 https://cdn.brandfetch.io/CIRC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Circle8 Says Dutch Unit Awarded $68M Annual Revenue Contract By Public Healthcare Body CAK, Starting January 1, 2027 openbell Financial News https://www.openbell.ai/news/CRM:1792497725245 2026-10-20T12:02:05.245Z daily 0.9 https://cdn.brandfetch.io/CRM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Salesforce To Acquire Braze For ~$5.66B openbell Financial News